Skip to content

Schrodinger

US · SDGR #2667 by market cap Listed 2020
27.29 -1.61 -5.57%
Live - 5344 symbols - heartbeat 74s ago · 2026-10-08 06:53
Pre-market 26.80 -1.80%
After-hours 27.20 -0.33%
Overnight 27.29 0.00%
Market cap
2.04B
P/B
6.21
EPS
-1.41
Reader sentiment Are you bullish or bearish on SDGR?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20
    Market Newswire · 2026/8/6
  • Rating change
    Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Cuts Target Price to $17
    Market Newswire · 2026/5/14
  • Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Maintains Target Price $17
    Market Newswire · 2026/8/6
  • Rating change
    BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $24
    Market Newswire · 2026/5/7
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN)
    TipRanks · 2026/2/26
  • Rating change
    Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Cuts Target Price to $19
    Market Newswire · 2026/1/8
  • UBS Initiates Schrodinger(SDGR.US) With Hold Rating, Announces Target Price $19
    Market Newswire · 2026/8/14
  • Rating change
    Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating, Announces Target Price $30
    Market Newswire · 2026/2/26
  • BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $24
    Market Newswire · 2026/8/18
  • Rating change
    TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20
    Market Newswire · 2026/8/6
  • Rating change
    TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20
    Market Newswire · 2026/2/26
  • Rating change
    BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20
    Market Newswire · 2026/2/26
  • Rating change
    Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating
    Market Newswire · 2026/7/9
  • Rating change
    Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Contineum Therapeutics, Inc. Class A (CTNM) and Schrodinger (SDGR)
    TipRanks · 2026/5/6
  • Rating change
    UBS Downgrades Schrodinger(SDGR.US) to Hold Rating, Cuts Target Price to $13
    Market Newswire · 2026/3/17
  • Rating change
    KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $25
    Market Newswire · 2026/1/8
  • Rating change
    KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20
    Market Newswire · 2026/4/13
  • Rating change
    TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $24
    Market Newswire · 2026/1/8
  • UBS Maintains Schrodinger(SDGR.US) With Hold Rating, Maintains Target Price $19
    Market Newswire · 2026/8/14
  • BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating
    Market Newswire · 2026/8/7

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 06:53:52 · For reference only, not investment advice and not tailored to your situation.